These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 2505716)

  • 1. [Contribution of perindopril to the treatment of chronic congestive cardiac insufficiency. Multicenter pilot double blind study versus placebo].
    Bounhoure JP; Bottineau G; Lechat P; Garnham J; Lapeyre G
    Arch Mal Coeur Vaiss; 1989 May; 82 Spec No 1():73-8. PubMed ID: 2505716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Value of perindopril in the treatment of chronic congestive heart failure. Multicenter double-blind placebo-controlled study.
    Bounhoure JP; Bottineau G; Lechat P; Garnham J; Lapeyre G
    Clin Exp Hypertens A; 1989; 11 Suppl 2():575-86. PubMed ID: 2691130
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Perindopril and chronic heart failure].
    Bounhoure JP
    Arch Mal Coeur Vaiss; 1991 Dec; 84 Spec No 4():89-92. PubMed ID: 1793331
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Significance of inhibitors of conversion enzymes in elderly subjects. The example of perindopril].
    Forette F; McClaran JM; Delesalle MC; Hervy MP; Bouchacourt P; Henry-Amar M; Santoni JP
    Arch Mal Coeur Vaiss; 1989 May; 82 Spec No 1():79-85. PubMed ID: 2505717
    [TBL] [Abstract][Full Text] [Related]  

  • 5. First-dose response to angiotensin-converting enzyme inhibition in congestive cardiac failure: a Malaysian experience.
    Navookarasu NT; Rahman AR; Abdullah I
    Int J Clin Pract; 1999; 53(1):25-30. PubMed ID: 10344062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Value of angiotensin converting enzyme inhibitors in the elderly: the example of perindopril.
    Forette F; McClaran J; Delesalle MC; Hervy MP; Bouchacourt P; Henry-Amar M; Santoni JP
    Clin Exp Hypertens A; 1989; 11 Suppl 2():587-603. PubMed ID: 2691131
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Distinctive properties of perindopril among converting enzyme inhibitors in congestive heart failure.
    Sami MH
    Can J Cardiol; 1994 Nov; 10 Suppl D():13D-16D. PubMed ID: 7954033
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The acute effect of perindopril upon effort capacity in congestive heart failure.
    Zdrenghea D; Angheloiu O; Icusca G; Timiş D
    Rom J Intern Med; 1994; 32(4):265-9. PubMed ID: 7613498
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The perindopril in elderly people with chronic heart failure (PEP-CHF) study.
    Cleland JG; Tendera M; Adamus J; Freemantle N; Polonski L; Taylor J;
    Eur Heart J; 2006 Oct; 27(19):2338-45. PubMed ID: 16963472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of perindopril on ambulatory intra-arterial blood pressure, cardiovascular reflexes and forearm blood flow in essential hypertension.
    West JN; Smith SA; Stallard TJ; Littler WA
    J Hypertens; 1989 Feb; 7(2):97-104. PubMed ID: 2647846
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Influence of ACE inhibition on glucose tolerance in patients with stable chronic renal failure.
    Fliser D; Rett K; Hübinger A; Ritz E
    Nephrol Dial Transplant; 1995; 10(5):643-7. PubMed ID: 7566576
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and acceptability of perindopril in mild to moderate chronic congestive heart failure.
    Lechat P; Garnham SP; Desche P; Bounhoure JP
    Am Heart J; 1993 Sep; 126(3 Pt 2):798-806. PubMed ID: 8166887
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiotensin-converting enzyme inhibitors and end-organ damage in heart failure.
    Sami M
    Can J Cardiol; 1999 May; 15 Suppl C():19C-23C. PubMed ID: 10380688
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hypertension, heart failure, myocardial infarction, secondary prevention: the role of perindopril].
    Rapezzi C; Ciliberti P; Graziosi M; Riva L
    Ital Heart J; 2005 Nov; 6 Suppl 7():40S-47S. PubMed ID: 16485516
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Therapeutic safety of perindopril in the treatment of mild hypertension with concomitant nephropathy.
    Bönner G; Lederle RM; Scholze J; Stumpe KO
    Arzneimittelforschung; 1993 Aug; 43(8):852-5. PubMed ID: 8216441
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of angiotensin-converting enzyme inhibition with perindopril on left ventricular remodeling and clinical outcome: results of the randomized Perindopril and Remodeling in Elderly with Acute Myocardial Infarction (PREAMI) Study.
    Ferrari R;
    Arch Intern Med; 2006 Mar; 166(6):659-66. PubMed ID: 16567606
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The angiotensin-converting enzyme inhibitor perindopril in the treatment of congestive heart failure].
    Tereshchenko SN; Drozdov VN; Demidova IV; Levchuk NN; Moiseev VS
    Ter Arkh; 1997; 69(7):53-6. PubMed ID: 9424761
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peripheral haemodynamic effects of perindopril compared in patients with congestive heart failure and in normal volunteers.
    Thuillez C; Richard C; Richer C; Loueslati H; Perret L; Auzépy P; Giudicelli JF
    J Hypertens Suppl; 1988 Dec; 6(3):S41-3. PubMed ID: 2852235
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Suppression of angiotensin-converting enzyme and myocardial ischemia].
    Eliseev OM
    Ter Arkh; 1999; 71(3):73-6. PubMed ID: 10234773
    [No Abstract]   [Full Text] [Related]  

  • 20. PROGRESS--perindopril protection against recurrent stroke study: status in July 1996. PROGRESS Management Committee.
    J Hypertens Suppl; 1996 Dec; 14(6):S47-51. PubMed ID: 9023716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.